RT Journal
A1 Mitka M
T1 GUidelines ease up on glycemic control for some patients with type 2 diabetes
JF JAMA
JO JAMA
YR 2012
FD June 6
VO 307
IS 21
SP 2243
OP 2244
DO 10.1001/jama.2012.5242
UL http://dx.doi.org/10.1001/jama.2012.5242
AB 
Aggressive glucose management has been a mainstay of diabetes treatment, intended to reduce microvascular risks such as diabetic nephropathy, neuropathy, and retinopathy. Physicians treating patients with diabetes have traditionally set a goal of achieving and keeping glycated hemoglobin (HbA1c) levels below 7.0%. But recent trials have suggested that achieving such a level may put certain patients with diabetes at risk for cardiovascular complications and mortality.